相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213
Ying-Yu Kuo et al.
CELL COMMUNICATION AND SIGNALING (2019)
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness
Amrita Singh Chandhoke et al.
ONCOTARGET (2017)
MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma
Chen Wang et al.
SCIENTIFIC REPORTS (2017)
Prostate cancer, PI3K, PTEN and prognosis
Helen M. Wise et al.
CLINICAL SCIENCE (2017)
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
Sean S. Q. Ma et al.
BMC CANCER (2016)
miR-199a-5p induces cell invasion by suppressing E-cadherin expression in cutaneous squamous cell carcinoma
Shaohua Wang et al.
ONCOLOGY LETTERS (2016)
Maternal Wnt/STOP signaling promotes cell division during early Xenopus embryogenesis
Ya-Lin Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
被撤回的出版物: Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho (Retracted article. See vol. 22, 2022)
Xu-Jun He et al.
BMC CANCER (2014)
SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer
X. Zhao et al.
CELL DEATH AND DIFFERENTIATION (2014)
Expression of Ror2 Mediates Invasive Phenotypes in Renal Cell Carcinoma
Neal R. Rasmussen et al.
PLOS ONE (2014)
MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS
Shanchao Zhang et al.
ARCHIVES OF VIROLOGY (2013)
The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis
Caroline E. Ford et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
Michael P. O'Connell et al.
CANCER DISCOVERY (2013)
Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell
Ning Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β
Masaaki Tsukigi et al.
CANCER LETTERS (2012)
The MicroRNA miR-199a-5p Down-regulation Switches on Wound Angiogenesis by Derepressing the v-ets Erythroblastosis Virus E26 Oncogene Homolog 1-Matrix Metalloproteinase-1 Pathway
Yuk Cheung Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
NF-κB Repression by PIAS3 Mediated RelA SUMOylation
Yuangang Liu et al.
PLOS ONE (2012)
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes
Arash Haghikia et al.
EUROPEAN HEART JOURNAL (2011)
Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
Ester Lara et al.
MOLECULAR CANCER (2010)
Systems analysis of EGF receptor signaling dynamics with microwestern arrays
Mark F. Ciaccio et al.
NATURE METHODS (2010)
Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
Debashis Sarker et al.
CLINICAL CANCER RESEARCH (2009)
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
Kanishka Sircar et al.
JOURNAL OF PATHOLOGY (2009)
Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma
T. M. Wright et al.
ONCOGENE (2009)
Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients
P. McCall et al.
BRITISH JOURNAL OF CANCER (2008)
Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase
Yan Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression end Akt activation
Roble Bedolla et al.
CLINICAL CANCER RESEARCH (2007)
The role of Wnts in bone metastases
Christopher L. Hall et al.
CANCER AND METASTASIS REVIEWS (2006)
Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis
Robert L. Vessella et al.
CLINICAL CANCER RESEARCH (2006)
Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation
Yoshitaka Ogata et al.
NEOPLASIA (2006)
Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context
AJ Mikels et al.
PLOS BIOLOGY (2006)
Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue et al.
ONCOGENE (2005)
Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer
JI Kreisberg et al.
CANCER RESEARCH (2004)
PIAS3 suppresses NF-κB-mediated transcription by interacting with the p65/RelA subunit
HD Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence
G Ayala et al.
CLINICAL CANCER RESEARCH (2004)
The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway
I Oishi et al.
GENES TO CELLS (2003)
Downregulation of PTEN/MMAC/TEP1 expression in human prostate cancer cell line DU145 by growth stimuli
DR Bastola et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells
M Gross et al.
ONCOGENE (2001)
Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells
A Junicho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
